MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • 2026 International Congress

    In Vivo 18F-Florzolotau Tau PET Imaging in Parkinson’s Disease with and without Probable REM Sleep Behavior Disorder

    C. Xu, Y. Tang, J. Wang (Shanghai, China)

    Objective: To investigate the distribution and potential influence of tau pathology in Parkinson’s disease (PD) patients with and without prodromal REM sleep behavior disorder (pRBD),…
  • 2026 International Congress

    FDG-PET-Based Machine Learning Differentiates Parkinson’s Disease from Other Neurodegenerative Disorders

    B. Song, P. Turcano, K. Ghoniem, C. Piat, E. Camerucci, J. Bower, L. Barnard, D. Jones, R. Savica (Rochester, USA)

    Objective: To evaluate whether a fluorodeoxyglucose positron emission tomography (FDG-PET) machine learning (ML) framework can be extended to differentiate Parkinson's disease (PD) from other neurodegenerative…
  • 2026 International Congress

    Quanti-tau-PET Study of PI‑2620 Tau-PET Quantification in Progressive Supranuclear Palsy

    Y. Compta, A. Niñerola-Baizan, C. Painous, R. Tudela, A. Camara, M. Fernandez, I. Zaro, S. Rubi, P. Bibiloni, A. Perissinotti (Barcelona, Spain)

    Objective: *Establish a quantitative analysis framework for PI‑2620 tau-PET in progressive supranuclear palsy (PSP);*Compare tau-PET uptake in PSP versus control subjects;*Assess correlations with clinical variables…
  • 2026 International Congress

    Diagnostic Utility of [18F]FDG-PET in the Differential Diagnosis of Parkinsonian Syndromes: A Retrospective Study in an Indian Tertiary Care Cohort

    A. Mani, J. Hephzibah (Ranipet, India)

    Objective: To evaluate the diagnostic utility of FDG-PET imaging for differentiating Parkinson's disease (PD), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal syndrome…
  • 2026 International Congress

    Clinico-radiological Phenotype of a Unique Family with Mutations in PRKN Over Three Decades

    M. Li, W. Liu, R. Mackinnon, C. Sue (Randwick, Australia)

    Objective: To report the clinico-radiological phenotype and progression of a female proband and her parents with mutations in the PRKN gene. Background: Bi-allelic PRKN mutations…
  • 2026 International Congress

    Quantitative Susceptibility Mapping Revealed Regional Iron Alteration and As a Biomarker for Dopaminergic Deficits in Parkinson’s Disease

    XY. Xie, HL. Wang, YL. Du, G. Wang (Shanghai, China)

    Objective: This study aimed to identify regions with altered brain iron accumulation using quantitative susceptibility mapping (QSM) and to investigate the association between iron deposition…
  • 2026 International Congress

    Multi-tracer positron emission tomography reveals early disruption of cerebrospinal fluid clearance in Huntington’s disease

    A. Calvano, F. Turkheimer, M. Veronese, M. Moretto, H. Tang, A. Wood, S. Williams, D. van Wamelen, J. Schubert (London, United Kingdom)

    Objective: To evaluate lateral ventricular (LV) positron emission tomography (PET) signal and choroid plexus (CP) volume as biomarkers of disease progression in Huntington’s disease (HD),…
  • 2026 International Congress

    Cerebellar cholinergic denervation relates to impaired gait and cerebellocortical resting-state functional connectivity in Parkinson disease

    B. Maiti, J. O'Donnell, K. Rawson, M. Owusu-Ansah, A. Tannenbaum, A. Eid, S. Grossen, J. Hood, S. Norris, M. Campbell, G. Earhart, J. Perlmutter (Saint Louis, USA)

    Objective: The purpose of this cross-sectional study was to investigate the cholinergic denervation of the cerebellum and its contribution to impaired gait and cerebellocortical resting-state…
  • 2026 International Congress

    Posterior Cortical Hypometabolism in GBA1 Variant Carriers with and without Parkinson’s Disease

    M. Avenali, R. Malito, P. Mitrotti, R. Calabrese, L. Gallo, T. Filidei, A. Panzacchi, A. Samanes Gajate, G. Pepe, R. Stiuso, M. Picascia, M. Todisco, L. Bandirali, P. Di Martino, D. Perani, A. Chiti, C. Tassorelli, E. Valente, S. Caminiti (Pavia, Italy)

    Objective: To investigate brain glucose metabolic patterns and their relationship with clinical features in GBA1 mutation carriers with PD (GBA-PD), asymptomatic carriers (GBA-nonPD), and PD…
  • 2026 International Congress

    Immune-mediated Chorea in Antiphospholipid Syndrome: Normalization of FDG-PET and Neurofilament as Markers of Treatment Response.

    L. Peraferrer-Montesinos, J. Martínez-Rodríguez, A. Fernández-Lebrero, M. Viles-Garcia, E. Carrillo Villamizar, P. Plaza-López, V. Puente-Periz, I. Navalpotro-Gómez (Barcelona, Spain)

    Objective: To present a case where FDG-PET and neurofilament findings help portray the reversibility of neuronal damage in antiphospholipid syndrome (aPL).   Background: Chorea is the most common movement disorder in aPL and often an initial manifestation, although…
  • 1
  • 2
  • 3
  • …
  • 40
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley